News
Novo Nordisk lowers Ozempic cost to $499 per month for uninsured U.S. patients, expanding access through NovoCare and 70,000 ...
GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...
21m
Asianet Newsable on MSNHealth Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1 mg demonstrated ...
VK2735 met its primary endpoint but failed to outdo competitors Novo Nordisk and Eli Lilly in terms of body weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results